Tuesday, March 18, 2025
spot_img

ProVen VCT plc: Director/PDMR Shareholding

ProVen VCT plc 

Director/PDMR Shareholding

17 March 2025

ProVen VCT plc (the ”Company”) hereby announces that on 17 March 2025, certain directors purchased ordinary shares of 10 pence each in the Company. This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details of which are set out below.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

James Kenneth Alexander Barbour-Smith

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ProVen VCT plc

b)

LEI

21380091P1TTU2Z2AW75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

   

GB00B8GH9P84

b)

Nature of the transaction

Purchase under Offer for Subscription

c)

Price(s) and volume(s)

Price(s) Volume(s)
 £0.6417 23,376

  

d)

Aggregated information

  Aggregate Price Aggregate Volume Aggregate Total
 

£0.6417

 

23,376

 

£15,000

e)

Date of the transaction

17 March 2025

f)

Place of the transaction

London

Beringea LLP
Company Secretary
Telephone 020 7845 7820

-End-

Powered by SlickText.com

Hot this week

Strong drilling results point to growth and upgrades in copper-gold resource

Infill results of up to 5.6% CuEq highlight potential...

Millicom’s Nomination Committee’s proposal for Board of Directors

Millicom’s Nomination Committee’s proposal for Board of Directors ...

Lithium Argentina Reports Fourth Quarter and Full Year 2024 Results

ZUG, Switzerland, March 17, 2025 (GLOBE NEWSWIRE)...

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 (GLOBE...

Topics

spot_img

Related Articles

Popular Categories

spot_img